Pfizer COVID-19 vaccine available for high-risk infants.
A smaller dose of the Pfizer Covid vaccine is approved for high risk infants 6 months or older. Approval is based on a single small US clinical trial and on Pfizer providing safety reports. A Government study shows vaccinated Kiwis suffered more kidney and heart injuries than the unvaccinated.
👉 More on this story: https://zcu.io/v4JU